Trial · NCT07887464
Clinical, Functional, and Therapeutic Characterization of Women With Urinary Incontinence and Analysis of Factors Associated With Treatment Response
NCT07887464, Not yet recruiting, Javier Pereira
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical, Functional, and Therapeutic Characterization of Women With Urinary Incontinence and Analysis of Factors Associated With Treatment Response. Trials, record NCT07887464. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887464
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical, Functional, and Therapeutic Characterization of Women With Urinary Incontinence and Analysis of Factors Associated With Treatment Response
- NCT number
- NCT07887464
- Status
- Not yet recruiting
- Enrollment
- 80 participants, estimated
- Lead sponsor
- Javier Pereira
- Conditions
- Urinary Incontinence (UI)
- Interventions
- Artificial intelligence clinical decision support model
- First posted
- 2026-10-21
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Severity of urinary incontinence (ICIQ-UI SF score) | Baseline (V0) through 12 months (V0, V1 at 3 months, V2 at 6 months, V3 at 12 months) | Total score on the ICIQ-UI SF (International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form), range 0-21, with higher scores indicating greater severity. Treatment response will be defined as an improvement ≥2.52 points (MCID). |
| Secondary | Overactive bladder symptoms (ICIQ-OAB) | V0(Day 1), V1 (3 months), V2 (6 months), V3 (12 months) | Score on the ICIQ-OAB questionnaire (8 items), range 0-16; higher scores indicate greater impairment. |
| Secondary | Incontinence severity - Sandvik Index (ISI) | V0(Day 1) and V2 (6 months) | Score on the Incontinence Severity Index (2 items), range 0-12, classified as mild/moderate/severe/very severe. |
| Secondary | Lower urinary tract symptom-specific quality of life (ICIQ-LUTSqol) | V0(Day 1), V1 (3 months), V2 (6 months), V3 (12 months) | Score on the ICIQ-LUTSqol questionnaire (19 items), range 19-76; higher scores indicate greater impairment in quality of life. |
| Secondary | Patient Global Impression of Severity (PGI-S) | V0 (baseline) | Single-item scale (1-4) assessing the patient's global perception of symptom severity. |
| Secondary | Patient Global Impression of Improvement (PGI-I) | V1 (3 months), V2 (6 months), V3 (12 months) | Single-item scale (1-7) assessing the patient's global perception of improvement relative to baseline. |
| Secondary | Sexual function (FSFI) | V0(Day 1), V1 (3 months), V2 (6 months), V3 (12 months) | Female Sexual Function Index (19 items, 6 domains), range 2-36; a cutoff score ≤26.55 indicates female sexual dysfunction. |
| Secondary | Pelvic floor muscle function (Oxford Scale ) | V0(Day 1) and V2 (6 months) | Pelvic floor muscle contraction strength will be assessed by vaginal palpation using the Oxford Scale, ranging from 0 (no contraction) to 5 (strong contraction). The outcome will be reported as the Oxford Scale score. |
| Secondary | Amount of urine loss (1-hour Pad Test, ICS) | V0(Day 1) and V2 (6 months) | Standardized 1-hour pad test; objective quantification of urine loss in grams. |
| Secondary | Voiding pattern (3-day Bladder Diary) | V0(Day 1) and V2 (6 months) | Voiding pattern and urinary symptoms will be assessed using a 3-day bladder diary. The recorded variables will include daytime and nighttime voiding frequency, urinary incontinence episodes per 24 hours, urgency episodes, voided urine volume, fluid intake, and pad use. Results will be reported for each recorded variable using the corresponding measurement unit. |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07887464
GET https://conductscience.org/api/trials/v1/NCT07887464/registered